CIT and COVID-19: During the initial stage of the COVID-19 pandemic, serum markers of NETs – myeloperoxidase (MPO)-DNA, and citrullinated histone H3 (Cit-H3) – were first reported to be elevated in the serum of COVID-19 patients [5].